SCHEMBL5477448

SCHEMBL5477448

CCN1CCN(CC(=O)Nc2sc3c(c2C(N)=O)CCOC3)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.64
HSD17B10 Q99714 4/20 0.64
KDM4E B2RXH2 4/20 0.64
ALOX15 P16050 2/20 0.64
TSHR P16473 4/20 0.59
HPGD P15428 3/20 0.59
GAA P10253 1/20 0.59
CFTR P13569 1/20 0.54
MAPK1 P28482 3/20 0.51
L3MBTL1 Q9Y468 3/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
POLB P06746 1/20 0.49
FLT3 P36888 1/20 0.49
ANO1 Q5XXA6 1/20 0.48
CDK2 P24941 1/20 0.47
USP2 O75604 1/20 0.47
TP53 P04637 1/20 0.47
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5449732 0.90 ALDH1A1 (0.73) ALDH1A1HSD17B10KDM4EALOX15TSHR
SCHEMBL5449658 0.89 ALDH1A1 (0.71) ALDH1A1HSD17B10KDM4EALOX15TSHR
SCHEMBL5451710 0.82 CFTR (0.58) ALDH1A1HSD17B10KDM4EALOX15TSHR
SCHEMBL5460139 0.79 CFTR (0.60) ALDH1A1HSD17B10KDM4EALOX15TSHR
SCHEMBL5445049 0.79 CFTR (0.60) ALDH1A1HSD17B10KDM4EALOX15TSHR
SCHEMBL5455157 0.79 CNR2 (0.69) ALDH1A1HSD17B10KDM4EALOX15TSHR
SCHEMBL5467138 0.79 CFTR (0.62) ALDH1A1HSD17B10KDM4EALOX15TSHR
SCHEMBL5459999 0.79 CFTR (0.54) ALDH1A1HSD17B10KDM4EALOX15GAA
SCHEMBL5454147 0.78 CFTR (0.59) ALDH1A1HSD17B10KDM4EALOX15TSHR
SCHEMBL5477459 0.78 ALDH1A1 (0.48) ALDH1A1HSD17B10KDM4EALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 US claimed
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents TBCA, PARK7, NFATC1 ALDH1A1 1153/4885HSD17B10 635/4885KDM4E 3417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.